Completed OBSERVATIONAL NCT05541978

Thrombosis in Patients With Multiple Myeloma in an University Medical Center (THRIMM)

Thrombosis in Newly Diagnosed Multiple Myeloma Patients: a Clinical Audit of Intermediate Dose Low Molecular Weight Heparin

Sponsor: Catalina Codreanu

Conditions Arterial Thromboembolism Multiple Myeloma Venous Thromboembolism

Interventions Multiple myeloma

Updated 6 times since 2022 Last updated: Jun 29, 2023 Started: Sep 1, 2022 Primary completion: Feb 1, 2023 Completion: Mar 1, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Arterial Thromboembolism and Multiple Myeloma and is currently completed. Catalina Codreanu leads this study, which shows 6 recorded versions since 2022 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Aug 2023 — Jul 2024 [monthly]

Completed
May 2023 — Aug 2023 [monthly]

Completed

Status: Recruiting → Completed
Dec 2022 — May 2023 [monthly]

Recruiting

▶ Show 1 earlier version

Sep 2022 — Dec 2022 [monthly]

Recruiting

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Catalina Codreanu

Data source: University Medical Center Groningen

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Groningen, Netherlands